Patent · US Active

Biomarkers for diabetes and usages thereof

US10100360B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

BGI SHENZHEN · CN

Inventors

Shenghui Li · Nanhu, CN
Qiang Feng · Qingdao, CN
Zhuye Jie · Nanhu, CN
Dongya Zhang · Tangxia, CN
Junjie Qin · Nanhu, CN
Jun Wang · Nanjing, CN
Jian-Ping Wang · Shoreview, US
Huanming Yang · Nanhu, CN

Key dates

Filing date	Jun 5, 2013
Grant date	Oct 16, 2018
Priority date	—
Expiry date	Jun 19, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Biomarkers for diabetes and usages thereof are provided. And the biomarkers are nucleotides having polynucleotide sequences defined in SEQ ID NOs: 1-50.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.